AAPL 220.794 -3.9943% MSFT 428.035 -0.2319% NVDA 141.6 2.8248% GOOGL 199.57 1.8214% GOOG 201.025 1.759% AMZN 231.2303 2.3415% META 615.98 0.5239% AVGO 241.67 1.7815% TSLA 419.8973 -1.5481% TSM 219.5101 3.7873% LLY 738.3 1.7335% V 323.35 1.167% JPM 263.1299 1.5318% UNH 524.13 2.819% NVO 80.9168 2.8298% WMT 93.0799 1.2398% LVMUY 146.6 3.1813% XOM 111.7187 -0.5353% LVMHF 732.5 3.0167% MA 527.97 0.6232%
AAPL 220.794 -3.9943% MSFT 428.035 -0.2319% NVDA 141.6 2.8248% GOOGL 199.57 1.8214% GOOG 201.025 1.759% AMZN 231.2303 2.3415% META 615.98 0.5239% AVGO 241.67 1.7815% TSLA 419.8973 -1.5481% TSM 219.5101 3.7873% LLY 738.3 1.7335% V 323.35 1.167% JPM 263.1299 1.5318% UNH 524.13 2.819% NVO 80.9168 2.8298% WMT 93.0799 1.2398% LVMUY 146.6 3.1813% XOM 111.7187 -0.5353% LVMHF 732.5 3.0167% MA 527.97 0.6232%

China Jo-Jo Drugstores Inc

Healthcare US CJJD

1.76USD
0.01(0.81%)

Last update at 2025-01-21T18:27:00Z

Day Range

1.761.84
LowHigh

52 Week Range

1.344.88
LowHigh

Fundamentals

  • Previous Close 1.75
  • Market Cap12.60M
  • Volume1192
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.76259M
  • Revenue TTM154.54M
  • Revenue Per Share TTM107.00
  • Gross Profit TTM 34.28M
  • Diluted EPS TTM-2.93

Financials

Income Statement

2019-03-312020-03-312021-03-312022-03-312023-03-31-20M0M20M40M60M80M100M120M140M160M
Total Revenue
Net Income

Balancesheet

2020-03-312021-03-312022-03-312023-03-312024-03-310M10M20M30M40M50M60M70M80M90M100M
Total Assets
Total Liabilities

Change in Cash

2019-03-312020-03-312021-03-312022-03-312023-03-31-6M-5M-4M-3M-2M-1M0M1M2M3M4M5M6M

Total Operating Cash

2019-03-312020-03-312021-03-312022-03-312023-03-31-7M-6.5M-6M-5.5M-5M-4.5M-4M-3.5M-3M-2.5M-2M-1.5M-1M-0.5M0M

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -20.74424M -2.09864M -8.34394M -6.44142M -1.18301M
Minority interest 0.00025M 0.00625M -1.34036M -1.81280M -1.19404M
Net income -21.13878M -3.19837M -8.37558M -6.45768M -1.31777M
Selling general administrative 15.67M 8.19M 10.90M 8.11M 1.72M
Selling and marketing expenses 29.18M 30.88M 26.95M 23.79M 24.27M
Gross profit 34.28M 36.52M 29.24M 25.53M 25.11M
Reconciled depreciation 0.72M 1.26M 1.75M 2.08M 1.68M
Ebit -10.56538M -2.54509M -8.60873M -6.37555M -0.54968M
Ebitda -7.28339M -0.43114M -5.97345M -3.43305M 1.13M
Depreciation and amortization 3.28M 2.11M 2.64M 2.94M 1.68M
Non operating income net other - - 0.88M 0.86M 0.02M
Operating income -10.56538M -2.54509M -8.60873M -6.37555M -0.54968M
Other operating expenses 159.38M 166.94M 141.74M 123.70M 108.43M
Interest expense 0.07M 0.26M 0.46M 0.70M 0.24M
Tax provision 0.39M 1.10M 0.03M 0.02M 0.13M
Interest income 0.88M 0.40M 0.71M 1.06M 0.11M
Net interest income 0.82M 0.14M 0.25M 0.37M 0.11M
Extraordinary items - - - - -
Non recurring - - 0.23M 0.63M -
Other items - - - - -
Income tax expense 0.39M 1.10M 0.03M 0.02M 0.13M
Total revenue 148.81M 164.39M 133.13M 117.33M 107.55M
Total operating expenses 44.85M 39.06M 37.85M 31.90M 25.98M
Cost of revenue 114.53M 127.87M 103.89M 91.80M 82.44M
Total other income expense net -10.17885M 0.45M 0.26M -0.06587M -0.63333M
Discontinued operations - - 0.26M 0.64M -
Net income from continuing ops -21.13878M -3.19837M -8.37558M -6.45768M -1.31777M
Net income applicable to common shares -21.13853M -3.19212M -8.11986M -5.81337M -1.31777M
Preferred stock and other adjustments - - - - -
Breakdown 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31
Type yearly yearly yearly yearly yearly
Date 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31
Total assets 95.06M 90.97M 106.38M 106.31M 99.52M
Intangible assets 3.65M 3.89M 4.32M 4.31M 4.39M
Earning assets - - - - -
Other current assets 13.29M 0.62M 0.92M 1.56M 0.16M
Total liab 80.76M 74.30M 83.65M 81.91M 80.74M
Total stockholder equity 15.64M 18.01M 24.09M 25.74M 20.59M
Deferred long term liab - - - - -
Other current liab 4.21M 4.46M 5.77M 4.08M 3.89M
Common stock 0.42M 0.28M 0.04M 0.04M 0.03M
Capital stock 0.42M 0.28M 0.04M 0.04M 0.03M
Retained earnings -73.50725M -69.27302M -48.13449M -44.94237M -36.40084M
Other liab - - - - 0.13M
Good will - -0.69154M -0.77006M -0.78557M -
Other assets - 2.49M 3.31M 2.45M 2.25M
Cash 20.15M 18.81M 18.46M 22.05M 16.18M
Cash and equivalents - - - - -
Total current liabilities 74.36M 66.54M 74.45M 64.90M 57.44M
Current deferred revenue 0.52M 0.70M 1.87M 1.15M 0.71M
Net debt 23.07M 23.35M 30.22M 24.74M 38.27M
Short term debt 37.07M 34.39M 39.48M 29.77M 31.28M
Short long term debt 31.95M 29.26M 36.15M 28.98M 30.30M
Short long term debt total 43.22M 42.16M 48.67M 46.78M 54.45M
Other stockholder equity 86.41M 83.96M 66.52M 66.52M 54.21M
Property plant equipment - 19.03M 19.66M 7.38M 8.38M
Total current assets 69.68M 64.48M 75.45M 72.23M 60.99M
Long term investments 1.20M 1.77M 4.42M 3.98M 2.54M
Net tangible assets - 14.82M 20.54M 22.21M 17.20M
Short term investments -12.72436M - 0.09M 0.09M 0.16M
Net receivables 19.08M 16.84M 22.50M 18.52M 14.90M
Long term debt - - - 1.89M 4.12M
Inventory 17.16M 15.31M 16.02M 16.97M 12.25M
Accounts payable 31.63M 26.99M 27.33M 29.90M 21.56M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - -1.34036M -1.81280M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.31M 3.04M 5.66M 4.13M 2.75M
Additional paid in capital - - - - -
Common stock total equity - - - 0.04M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -44.94237M -36.40084M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.80M 1.46M 3.31M 1.69M 0.79M
Deferred long term asset charges - - - - -
Non current assets total 25.37M 26.49M 30.93M 34.08M 38.53M
Capital lease obligations 11.27M 12.90M 12.53M 15.91M 20.03M
Long term debt total - - - 1.89M 4.12M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -0.31610M -0.30614M -1.39415M -2.55273M -0.01707M
Change to liabilities 1.77M -3.55805M 6.26M -1.28539M -1.07362M
Total cashflows from investing activities -0.31610M -0.30614M -1.99832M -4.83661M -7.32618M
Net borrowings -4.12014M 4.15M -6.28475M 9.74M 7.99M
Total cash from financing activities 2.37M 4.84M 3.08M 19.01M 8.08M
Change to operating activities -2.46584M -0.83068M 1.75M -2.48419M -4.48724M
Net income -21.13878M -3.19837M -8.37558M -6.45768M -1.31777M
Change in cash -3.76893M 0.67M 3.69M 6.24M -6.70699M
Begin period cash flow 35.34M 34.67M 30.98M 24.75M 31.45M
End period cash flow 31.57M 35.34M 34.67M 30.98M 24.75M
Total cash from operating activities -3.28351M -5.38597M -0.06229M -6.90794M -5.60322M
Issuance of capital stock 7.33M 0.00000M 9.29M 9.27M 0.00753M
Depreciation 0.72M 1.26M 1.75M 2.08M 1.68M
Other cashflows from investing activities - - -0.47741M -1.52744M -0.02982M
Dividends paid - - - - -
Change to inventory -0.52255M 1.52M -3.61502M 0.98M -1.39082M
Change to account receivables -2.53175M -2.65728M -3.30795M -1.56777M -0.11681M
Sale purchase of stock - - 9.29M 9.27M 0.00753M
Other cashflows from financing activities 57.13M 66.06M 49.03M 57.30M 42.01M
Change to netincome 20.26M 1.08M 3.40M 0.71M -2.83430M
Capital expenditures 0.31M 0.31M 0.60M 2.28M 7.31M
Change receivables - - -2.81744M -2.46569M -1.34134M
Cash flows other operating - - 1.44M -0.61852M -2.93424M
Exchange rate changes - - 2.67M -1.03174M -1.85617M
Cash and cash equivalents changes - - 3.69M 6.24M -6.70699M
Change in working capital -3.11962M -4.53261M 3.16M -3.24103M -3.12756M
Stock based compensation 10.36M 0.00000M 3.94M 0.03M 0.20M
Other non cash items 9.90M 1.09M -0.54245M 0.67M -3.03140M
Free cash flow -3.59523M -5.69211M -0.66647M -9.19183M -12.91233M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CJJD
China Jo-Jo Drugstores Inc
0.01 0.81% 1.76 - - 0.08 0.79 0.23 28.93
WBA
Walgreens Boots Alliance Inc
-1.665 13.30% 10.86 - 5.40 0.11 1.14 0.33 -4.3066
RADLY
Raia Drogasil SA ADR
0.12 3.37% 3.68 47.15 32.68 0.34 9.83 0.35 3.29
ALBHF
Alibaba Health Information Technology Limited
-0.014 3.08% 0.44 50.80 29.59 0.30 3.62 1.58 34.83
ALBBY
Alibaba Health Information Technology Limited
0.11 1.28% 8.50 48.10 30.30 0.29 3.70 1.58 34.83

Reports Covered

Stock Research & News

Profile

China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours. In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing. Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms. Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates pharmacies under the Jiuzhou Grand Pharmacy name. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China.

China Jo-Jo Drugstores Inc

Building 5, Hangzhou, China, 310008

Key Executives

Name Title Year Born
Mr. Lei Liu Chairman & CEO 1964
Mr. Ming Zhao Chief Financial Officer 1976
Steve Liu Investor Relations Director NA
Mr. Yan Liu Sec. 1990
Mr. Yan Liu Secretary 1990
Mr. Lei Liu M.D. Chairman & CEO 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.